[Wastewater-based Epidemiology Surveillance Service]
By measuring the traces of the virus in wastewater, it is possible to assess, in an unbiased manner, the prevalence of SARS-CoV-2 infections in a community, including asymptomatic individuals who are not tested.
［Mid-term Business plan］
~Shionogi Transformation Strategy 2030~
Outline / CEO interview movie
Create innovations beyond the borders of medical / Pharmaceutical fields, unbound from existing concepts, showing every consideration for social issues
Grow sustainably as a drug discovery based pharmaceutical company contributing to a more vigorous society through improved healthcare
Building innovation platforms to shape the future of healthcare.
SHIONOGI is transforming our business model from a "drug-discovery-oriented pharmaceutical company" to a "healthcare provider" to pursue the health that people truly wish for and deliver new value to society.